Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Scarab Genomics in March, 2019 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI094823-04A1 | Phase II | 1,000,000 | March 20, 2019 | |||||||
A SBIR Phase II contract was awarded to Scarab Genomics in July, 2020 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI155307-01 | Phase II | 1,000,000 | July 13, 2020 | |||||||
A SBIR Phase II contract was awarded to Scarab Genomics in July, 2019 for $911,189.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI143170-02 | Phase II | 911,189 | July 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Scarab Genomics in January, 2019 for $156,171.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI143170-01 | Phase I | 156,171 | January 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Scarab Genomics in June, 2016 for $2,418,530.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM105177-02 | Phase II | 2,418,530 | June 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Scarab Genomics in May, 2014 for $1,461,610.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI094823-02 | Phase II | 1,461,610 | May 20, 2014 | |||||||
A SBIR Phase I contract was awarded to Scarab Genomics in December, 2016 for $154,222.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AI129149-02 | Phase I | 154,222 | December 15, 2016 | |||||||
A SBIR Phase II contract was awarded to Scarab Genomics in August, 2017 for $1,584,682.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AI129149-02 | Phase II | 1,584,682 | August 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Scarab Genomics for $109,429.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44GM071352-01 | Phase I | 109,429 | ||||||||
A SBIR Phase II contract was awarded to Scarab Genomics for $1,748,517.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AI088981-02 | Phase II | 1,748,517 | ||||||||
A SBIR Phase I contract was awarded to Scarab Genomics for $127,387.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI091269-01 | Phase I | 127,387 | ||||||||
A SBIR Phase II contract was awarded to Scarab Genomics for $1,624,414.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44GM105183-02 | Phase II | 1,624,414 | ||||||||
A SBIR Phase II contract was awarded to Scarab Genomics for $1,825,980.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM080799-02 | Phase II | 1,825,980 | ||||||||
A SBIR Phase I contract was awarded to Scarab Genomics for $139,203.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM080799-01 | Phase I | 139,203 | ||||||||
A SBIR Phase I contract was awarded to Scarab Genomics for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI055077-01A2 | Phase I | 100,000 | ||||||||
A SBIR Phase II contract was awarded to Scarab Genomics for $1,041,260.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44GM071352-02 | Phase II | 1,041,260 | ||||||||
A SBIR Phase I contract was awarded to Scarab Genomics for $155,032.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44GM105183-01 | Phase I | 155,032 | ||||||||
A SBIR Phase I contract was awarded to Scarab Genomics for $141,037.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM079052-01A2 | Phase I | 141,037 | ||||||||
A SBIR Phase I contract was awarded to Scarab Genomics for $282,618.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM105177-01 | Phase I | 282,618 | ||||||||
A SBIR Phase I contract was awarded to Scarab Genomics for $140,925.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI094823-01A1 | Phase I | 140,925 | ||||||||
A SBIR Phase I contract was awarded to Scarab Genomics for $1,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI063821-01A2 | Phase I | 1,000,000 | ||||||||
A SBIR Phase I contract was awarded to Scarab Genomics for $139,981.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AI088981-01 | Phase I | 139,981 | ||||||||
A SBIR Phase II contract was awarded to Scarab Genomics for $1,337,280.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI055077-02 | Phase II | 1,337,280 |